Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis

被引:97
作者
Horn, P. [1 ]
Bork, S. [1 ,2 ]
Diehlmann, A. [1 ]
Walenda, T. [1 ]
Eckstein, V. [1 ]
Ho, A. D. [1 ]
Wagner, W. [1 ,3 ]
机构
[1] Heidelberg Univ, Dept Med 5, D-69120 Heidelberg, Germany
[2] Heidelberg Acad Sci & Humanities, Heidelberg, Germany
[3] Heidelberg Univ, Dept Physiol & Pathophysiol, D-69120 Heidelberg, Germany
关键词
CD271; density-gradient centrifugation; fibroblastic colony-forming units; heterogeneity; isolation methods; mesenchymal stromal cells; morphology; red blood cell lysis;
D O I
10.1080/14653240802398845
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Background Human mesenchymal stromal cells (MSC) have raised high hopes for tissue engineering and clinical therapy. Their isolation usually involves density fractionation of mononuclear cells (MNC) but this is difficult to standardize, especially under good manufacturing practice (GMP) conditions. MSC represent a heterogeneous mixture of cell types and the composition of subpopulations is affected by the initial steps of cell preparation. Methods This study describes a straightforward method for isolation of human MSC based on red blood cell (RBC) lysis with ammonium chloride. Colony formation was compared directly with Ficoll density fractionation and culture of an untreated whole bone marrow (BM) aspirate. Results After 7 days the number of fibroblastic colony-forming units (CFU-F) per milliliter of BM aspirate was slightly higher upon RBC lysis and the colonies were significantly larger compared with density fractionation, possibly because of maintenance of platelets. In contrast, colony formation was much lower in untreated BM. The heterogeneous composition of subpopulations was reflected by differences between the initial colonies with regard to growth pattern (tight or disperse) and cell morphology (round or elongated). This heterogeneous composition was not affected by the three different isolation methods. Furthermore, enrichment of CD271+ cells resulted in the same morphologic heterogeneity. All cell preparations demonstrated the same immunophenotype using a panel of surface markers and displayed adipogenic and osteogenic differentiation potential. Discussion This study demonstrates that human MSC can be efficiently isolated by RBC lysis. This technique is faster and can be standardized more easily for clinical application of MSC.
引用
收藏
页码:676 / 685
页数:10
相关论文
共 33 条
[1]
Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood [J].
Bieback, K ;
Kern, S ;
Klüter, H ;
Eichler, H .
STEM CELLS, 2004, 22 (04) :625-634
[2]
Novel markers for the prospective isolation of human MSC [J].
Buehring, Hans-Joerg ;
Battula, Venkata Lokesh ;
Treml, Sabrina ;
Schewe, Bernhard ;
Kanz, Lothar ;
Vogel, Wichard .
HEMATOPOIETIC STEM CELLS VI, 2007, 1106 :262-271
[3]
Functional and immunophenotypic characteristics of isolated CD105+ and fibroblast+ stromal cells from AML:: implications for their plasticity along endothelial lineage [J].
Campioni, D ;
Lanza, F ;
Moretti, S ;
Dominici, M ;
Punturieri, M ;
Pauli, S ;
Hofmann, T ;
Horwitz, E ;
Castoldi, GL .
CYTOTHERAPY, 2003, 5 (01) :66-79
[4]
Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow [J].
Colter, DC ;
Class, R ;
DiGirolamo, CM ;
Prockop, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3213-3218
[5]
Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells [J].
Colter, DC ;
Sekiya, I ;
Prockop, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (14) :7841-7845
[6]
Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts [J].
Covas, Dimas T. ;
Panepucci, Rodrigo A. ;
Fontes, Aparecida M. ;
Silva, Wilson A., Jr. ;
Orellana, Maristela D. ;
Freitas, Marcela C. C. ;
Neder, Luciano ;
Santos, Anemari R. D. ;
Peres, Luiz C. ;
Jamur, Maria C. ;
Zago, Marco A. .
EXPERIMENTAL HEMATOLOGY, 2008, 36 (05) :642-654
[7]
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J].
Dominici, M. ;
Le Blanc, K. ;
Mueller, I. ;
Slaper-Cortenbach, I. ;
Marini, F. C. ;
Krause, D. S. ;
Deans, R. J. ;
Keating, A. ;
Prockop, D. J. ;
Horwitz, E. M. .
CYTOTHERAPY, 2006, 8 (04) :315-317
[8]
Good manufacturing practice-compliant expansion of marrow-derived stem and progenitor cells for cell therapy [J].
Gastens, Martin H. ;
Goltry, Kristin ;
Prohaska, Wolfgang ;
Tschoepe, Diethelm ;
Stratmann, Bernd ;
Lamnmers, Dirk ;
Kirana, Stanley ;
Goetting, Christian ;
Kleesiek, Knut .
CELL TRANSPLANTATION, 2007, 16 (07) :685-696
[9]
CELL-SURFACE ANTIGENS ON HUMAN MARROW-DERIVED MESENCHYMAL CELLS ARE DETECTED BY MONOCLONAL-ANTIBODIES [J].
HAYNESWORTH, SE ;
BABER, MA ;
CAPLAN, AI .
BONE, 1992, 13 (01) :69-80
[10]
Heterogeneity of mesenchymal stromal cell preparations [J].
Ho, A. D. ;
Wagner, W. ;
Franke, W. .
CYTOTHERAPY, 2008, 10 (04) :320-330